SEC Form 4 · Rule 10b5-1 trading plans

Centessa Pharmaceuticals plc (CNTA)

32Trades filed under a plan
6Plan adoption dates stated
4Quarterly results prints on file
1Trades in the days before a print

In the 2025 filing year, Centessa Pharmaceuticals plc filed 24 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 7 reporting owners, covering 32 transactions filed under those plans and 502,948 shares. None carries the SEC's own AFF10B5ONE adoption flag; each of the 24 names a plan in a footnote. 4 results prints are on file in the same window, which is what makes the interval below measurable.

Trades filed under a plan in Centessa Pharmaceuticals plc 32

Plan adoption dates stated in Centessa Pharmaceuticals plc 6

Quarterly results prints on file in Centessa Pharmaceuticals plc 4

Trades in the days before a print in Centessa Pharmaceuticals plc 1

Interval to the next reported results date

For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.

1Within 5 days of a print
4Within 10 days of a print
4Shortest interval, in days
0Trades with no later print on file

Adoption dates, as the filings state them

As the filings state it: “10b5-1 trading plan adopted by the Reporting Person on February 14, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Order the document

Every company with plan records →

Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.